399 related articles for article (PubMed ID: 19008150)
41. New goals set for filariasis elimination in India.
Sharma DC
Lancet Infect Dis; 2002 Jul; 2(7):389. PubMed ID: 12127343
[No Abstract] [Full Text] [Related]
42. Filarial lymphoedema and alpha-1-adrenergic receptor blockade.
Godbole RE; Godbole HR
J Assoc Physicians India; 2002 Mar; 50():459-60. PubMed ID: 11922252
[No Abstract] [Full Text] [Related]
43. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
Kumar A; Sachan P
Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
[TBL] [Abstract][Full Text] [Related]
44. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Kirodian BG; Ingole NS; Mehendale AM; Fleckenstein L; Karbwang J; Lazdins-Helds JK
Trans R Soc Trop Med Hyg; 2004 Apr; 98(4):205-17. PubMed ID: 15049459
[TBL] [Abstract][Full Text] [Related]
45. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
Sahoo PK; Satapathy AK; Michael E; Ravindran B
Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
[TBL] [Abstract][Full Text] [Related]
46. Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
Shenoy RK; Suma TK; Kumaraswami V; Rahmah N; Dhananjayan G; Padma S
Ann Trop Med Parasitol; 2009 Apr; 103(3):235-47. PubMed ID: 19341538
[TBL] [Abstract][Full Text] [Related]
47. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
Chanteau S; Roux JF
Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
[TBL] [Abstract][Full Text] [Related]
48. Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
Abd Elaziz KM; El-Setouhy M; Bradley MH; Ramzy RM; Weil GJ
Am J Trop Med Hyg; 2013 Aug; 89(2):260-4. PubMed ID: 23751402
[TBL] [Abstract][Full Text] [Related]
49. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
Nandha B; Krishnamoorthy K
Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
[TBL] [Abstract][Full Text] [Related]
50. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
51. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India.
Kumar A; Kumar P; Nagaraj K; Nayak D; Ashok L; Ashok K
J Vector Borne Dis; 2009 Sep; 46(3):237-40. PubMed ID: 19724089
[No Abstract] [Full Text] [Related]
52. Lymphatic filariasis.
Thompson B
Nurs Times; 2001 Sep 20-26; 97(38):59-60. PubMed ID: 11935860
[No Abstract] [Full Text] [Related]
53. Lymphatic filariasis in India: epidemiology and control measures.
Raju K; Jambulingam P; Sabesan S; Vanamail P
J Postgrad Med; 2010; 56(3):232-8. PubMed ID: 20739779
[TBL] [Abstract][Full Text] [Related]
54. Major progress toward eliminating lymphatic filariasis.
Ottesen EA
N Engl J Med; 2002 Dec; 347(23):1885-6. PubMed ID: 12466515
[No Abstract] [Full Text] [Related]
55. Mass drug administration to eliminate lymphatic filariasis in India.
Ramaiah KD; Das PK
Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
Mani TR; Rajendran R; Sunish IP; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2004 Sep; 9(9):1030-5. PubMed ID: 15361118
[TBL] [Abstract][Full Text] [Related]
57. Pacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
Dean M
Lancet; 2003 Dec; 362(9399):1906. PubMed ID: 14672081
[No Abstract] [Full Text] [Related]
58. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Gustavsen KM; Bradley MH; Wright AL
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
[TBL] [Abstract][Full Text] [Related]
59. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
Mohammed KA; Molyneux DH; Albonico M; Rio F
Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Irvine MA; Stolk WA; Smith ME; Subramanian S; Singh BK; Weil GJ; Michael E; Hollingsworth TD
Lancet Infect Dis; 2017 Apr; 17(4):451-458. PubMed ID: 28012943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
